Raymond James & Associates’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,187
Closed -$212K 3629
2017
Q4
$212K Buy
4,187
+99
+2% +$5.42K ﹤0.01% 3023
2017
Q3
$234K Sell
4,088
-121
-3% -$6.04K ﹤0.01% 2948
2017
Q2
$218K Buy
+4,209
New +$217K ﹤0.01% 2930

Other funds holding LDL

Raymond James & Associates's LDL Position: Q1 2018 in Review

Raymond James & Associates sold out of Lydall, Inc. (LDL) in Q1 2018, closing a stake of 4,187 shares — an estimated $212K sold.

Raymond James & Associates first reported a position in LDL in Q2 2017 and held it in 3 quarters. The position peaked at $234K in Q3 2017. 157 funds tracked by Wall St. Rank hold LDL as of Q1 2018.

  • Raymond James & Associates reported no remaining Lydall, Inc. position as of Q1 2018 after selling out during the quarter.
  • Raymond James & Associates sold 4,187 Lydall, Inc. shares in Q1 2018, an estimated $212K.
  • Raymond James & Associates first reported a position in Lydall, Inc. in Q2 2017 and held it in 3 quarters.
  • Raymond James & Associates's Lydall, Inc. position peaked at $234K in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2018.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.